- Home
- NGNE vs WOW Comparison
NGNE vs WOW Comparison
Compare NGNE & WOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- WOW
- Stock Information
- Founded
- NGNE 2003
- WOW 2001
- Country
- NGNE United States
- WOW United States
- Employees
- NGNE N/A
- WOW N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- WOW Cable & Other Pay Television Services
- Sector
- NGNE Health Care
- WOW Telecommunications
- Exchange
- NGNE Nasdaq
- WOW Nasdaq
- Market Cap
- NGNE 325.3M
- WOW 285.5M
- IPO Year
- NGNE N/A
- WOW 2017
- Fundamental
- Price
- NGNE $20.51
- WOW $5.07
- Analyst Decision
- NGNE Strong Buy
- WOW Hold
- Analyst Count
- NGNE 7
- WOW 2
- Target Price
- NGNE $41.86
- WOW $5.20
- AVG Volume (30 Days)
- NGNE 123.0K
- WOW 3.2M
- Earning Date
- NGNE 08-11-2025
- WOW 08-11-2025
- Dividend Yield
- NGNE N/A
- WOW N/A
- EPS Growth
- NGNE N/A
- WOW N/A
- EPS
- NGNE N/A
- WOW N/A
- Revenue
- NGNE N/A
- WOW $604,800,000.00
- Revenue This Year
- NGNE N/A
- WOW N/A
- Revenue Next Year
- NGNE N/A
- WOW N/A
- P/E Ratio
- NGNE N/A
- WOW N/A
- Revenue Growth
- NGNE N/A
- WOW N/A
- 52 Week Low
- NGNE $6.88
- WOW $3.06
- 52 Week High
- NGNE $74.49
- WOW $5.80
- Technical
- Relative Strength Index (RSI)
- NGNE 47.72
- WOW 77.85
- Support Level
- NGNE $18.94
- WOW $3.06
- Resistance Level
- NGNE $21.59
- WOW $5.09
- Average True Range (ATR)
- NGNE 1.40
- WOW 0.14
- MACD
- NGNE -0.26
- WOW 0.22
- Stochastic Oscillator
- NGNE 32.30
- WOW 98.77
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.